Product Information

VENLAFAXINE HCL ER 150 MG TAB is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.2333 per EA under NDC 75834021830. Its NADAC has been published 340 times since Feb 19, 2020.

FDA first approved this application on Aug 29, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VENLAFAXINE HCL ER 150 MG TAB

VENLAFAXINE HYDROCHLORIDE
$0.2333per EA

Strength

150 mg/1

NDC

75834021830

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VENLAFAXINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA211323

FDA Approved

8/29/2019

TE Code

AB

On Market Since

9/6/2019

Pharmacological Classes

Norepinephrine Uptake Inhibitors
Serotonin Uptake Inhibitors
Serotonin and Norepinephrine Reuptake Inhibitor

Price Statistics

The NADAC for VENLAFAXINE HCL ER 150 MG TAB has been published 340 times since Feb 19, 2020, and over the history we have for it it has declined 94.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2333 per EA
All-time high$4.3632 (Mar 11, 2020)
All-time low$0.1711 (May 22, 2024)
52-week high$0.3110
52-week low$0.2085
Median price$0.3135
Average price$1.4239
Largest weekly change+83.6% (Jun 19, 2024)
Weeks tracked340
Tracking sinceFeb 19, 2020

Price History

1W

+8.3%

1M

+8.3%

3M

-11.6%

6M

-18.5%

1Y

-12.3%

3Y

+25.9%

5Y

-93.6%

All

-94.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VENLAFAXINE HCL ER 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG TAB, manufactured by Nivagen Pharmaceuticals Inc., is $0.2333 per EA (NDC 75834021830), effective Aug 19, 2026.

How has the price of VENLAFAXINE HCL ER 150 MG TAB changed over time?

Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has declined 94.7%. It has been tracked across 340 weekly CMS publications since Feb 19, 2020.

What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG TAB?

Since Feb 19, 2020, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has ranged from a low of $0.1711 (May 22, 2024) to a high of $4.3632 (Mar 11, 2020), with a median of $0.3135 per EA.

Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG TAB?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VENLAFAXINE HCL ER 150 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures VENLAFAXINE HCL ER 150 MG TAB?

VENLAFAXINE HCL ER 150 MG TAB (NDC 75834021830) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.